Chicago Infectious Diseases is categorized under Doctors in Chicago, IL and active since 2001.
Chicago Infectious Diseases was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Nicolas Vogel, Office Manager at the company’s single location by writing to 4553 North Magnolia Avenue Apartment 509, Chicago, Illinois IL 60640 or by phoning (773) 769-0321. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chicago Infectious Diseases |
| Contact Person: | Nicolas Vogel, Office Manager |
| Address: | 4553 North Magnolia Avenue Apartment 509, Chicago, Illinois 60640 |
| Phone Number: | (773) 769-0321 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Chicago Infectious Diseases was started in 2001 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Nicolas Vogel, Office Manager for inquiries that concern Chicago Infectious Diseases by calling the company number (773) 769-0321, as your correspondence is most welcome. Additionally, the physical location of the single location of Chicago Infectious Diseases can be found at the coordinates 41.96473,-87.660933 as well as the street address 4553 North Magnolia Avenue Apartment 509 in Chicago, Illinois 60640.
For its online presence, you may visit Chicago Infectious Diseases’s website at and engage with its social media outlets through on Twitter and on Facebook.